TIANFU CHEM Imatinib mesylate

Details:

Product Name: Imatinib mesylate
Synonyms: 4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate;STI-571;IMATINIB BASE(IMA-3);ImatinibMesylate/Gleevec;Imatinib Methanesulfonate, STI-571, CGP-57148B, Glivec,;IMATINIB MESYLATE (IMATINIB METHANESULFONATE);alpha-IMATINIB MESYLATE;Imatinib mesylate(TINIBS )
CAS: 220127-57-1
MF: C30H35N7O4S
MW: 589.71
EINECS:
Product Categories: Active Pharmaceutical Ingredients;Intermediates & Fine Chemicals;Pharmaceuticals;Tyrosine Kinase Inhibitors;Aromatics;Heterocycles;API;Glivec, CGP-57148B, STI-571;Antineoplastic;Anti-cancer&immunity;Inhibitors;Anticancer
Mol File: 220127-57-1.mol
Imatinib mesylate Structure
Imatinib mesylate Chemical Properties
Melting point  214-224°C
storage temp.  -20°C Freezer
solubility  H2O: soluble10mg/mL, clear
color  white to beige
CAS DataBase Reference 220127-57-1(CAS DataBase Reference)
Safety Information
Hazard Codes  Xn
Risk Statements  22
RTECS  CV5520550
Hazardous Substances Data 220127-57-1(Hazardous Substances Data)
MSDS Information
Imatinib mesylate Usage And Synthesis
a small-molecule inhibitor Imatinib mesylate (also called Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl, the causal agent in chronic myelogenous leukemia.
As an inhibitor of PDGFR, imatinib mesylate appears to have utility in the treatment of a variety of dermatological diseases. Imatinib has been reported to be an effective treatment for FIP1L1-PDGFRalpha+ mast cell disease, hypereosinophilic syndrome, and dermatofibrosarcoma protuberans.
Chemical Properties Off-White Solid
Uses A tyrosine kinase inhibitor. Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL)
Uses Imatinib Mesylate is orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM, respectively. Imatinib also known as Gleevec, Glivec, CGP-57148B, STI-571 & Imatinib
Uses Imatinib Mesylate (STI571) is an orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM, respectively.